After reaching a goal weight, many people wonder if they can maintain their results with less medication
Some insurers now cover Wegovy specifically for cardiovascular risk reduction in patients with established heart disease and obesity, even when their weight-loss-only formulary excludes it
Karmaus, Hogberg, Kleinstreuer and colleagues (Frontiers in Toxicology, 2026) reviewed published variability analyses across in vivo guideline study types
GLP-1 treatments are not for everyone, Bakshi stresses, and like all medications, they can cause unpleasant side effects
Women tend to notice this sooner and more acutely than men, partly because women typically start with longer hair that makes shedding more visible, and partly because the female demographic is disproportionately affected